Integrating Cardiopulmonary Exercise Testing, Stress Echocardiography and Near-Infrared Spectroscopy for Multimodal Assessment of Exercise Intolerance: A Narrative Review
Abstract
1. Introduction
2. Methods
3. Core Modalities: CPET, Stress Echocardiography and Near-Infrared Spectroscopy
3.1. Cardiopulmonary Exercise Testing
3.2. Stress Echocardiography
3.3. Near-Infrared Spectroscopy
4. Rationale and Methodology for Integrated CPET, Stress Echocardiography and NIRS
4.1. Complementary Physiological Domains
4.2. Proposed Integrated Protocols and Practical Workflow
- Pre-test: Baseline spirometry is recommended to identify obstructive or restrictive patterns.
- Exercise protocol: A total exercise duration of 8–12 min with a progressive ramp protocol (8–20 W/min) is advised, in accordance with CPET guidelines [1]. Continuous ECG, blood pressure, peripheral oxygen saturation, and breath-by-breath gas exchange monitoring are essential. The exercise protocol must be performed following a brief warm-up phase for initial NIRS signal stabilization, system calibration, and adaptation to pedaling-related motion artifacts
- Echocardiographic imaging: To be acquired at rest, low workload (<100 bpm), anaerobic threshold, and peak exercise. Parameters to assess include left ventricular systolic and diastolic function, valvular abnormalities, cardiac output (calculated via LVOT VTI), right ventricular function (e.g., TAPSE, TAPSE/PASP), pulmonary arterial pressure (PASP), and pulmonary congestion (assessed via B-lines on lung ultrasound).
- NIRS monitoring: The sensor should be positioned over a target muscle (e.g., quadriceps femoris muscle), ensuring secure fixation to minimize motion artifacts and reduce ambient light interference. Subcutaneous adipose tissue thickness (ATT) should be considered due to its impact on signal quality. The monitoring protocol follows a structured timeline to ensure data reliability:
- Warm-up and Calibration: A preliminary phase is essential for signal stabilization and baseline calibration. During the warm-up, the system adjusts to motion artifacts inherent to the pedaling action, ensuring that subsequent readings are physiologically grounded.
- Continuous Measurement: Data acquisition must remain uninterrupted throughout the exercise phase and the subsequent recovery phase.
- Active Recovery and Termination: To prevent abrupt changes in limb position from compromising the sampling accuracy, the patient should continue pedaling during the recovery phase. Monitoring should only be terminated once the variables have reached a post-exercise plateau (i.e., when parameters no longer show significant fluctuations).
Key parameters include: - O2Hb (Oxyhemoglobin): Represents the amount of hemoglobin that is bound to oxygen. A decrease during exercise typically suggests that the local metabolic demand is exceeding the oxygen supply being delivered by the blood flow.
- HHb (Deoxyhemoglobin): Represents hemoglobin that has released its oxygen (reduced hemoglobin). It is considered a highly sensitive indicator of tissue oxygen extraction.
- tHb (Total Hemoglobin): Sum of O2Hb and HHb, serves as a proxy for local blood volume in the tissue under the sensor
- DiffHb (Hemoglobin Difference): Difference between O2Hb and HHb, used as an index of tissue O2 extraction
- TSI (Tissue Saturation Index): The ratio between O2Hb and tHb (expressed as a percentage). Reflects an index of changes in tissue O2 saturation, indicating the balance between oxygen delivery and consumption.
4.3. Potential Artifacts and Limitations
5. Results and Discussion: Clinical Applications of Multimodal Exercise Assessment
5.1. Heart Failure
5.2. Pulmonary Hypertension
5.3. Peripheral Artery Disease
5.4. Sports Cardiology and Athletic Performance Assessment
5.5. Cardiomyopathies
5.6. Practical Considerations and Barriers to Clinical Implementation
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Guazzi, M.; Arena, R.; Halle, M.; Piepoli, M.F.; Myers, J.; Lavie, C.J. 2016 focused update: Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur. Heart J. 2018, 39, 1144–1161. [Google Scholar] [CrossRef] [PubMed]
- Malhotra, R.; Bakken, K.; D’Elia, E.; Lewis, G.D. Cardiopulmonary Exercise Testing in Heart Failure. JACC Heart Fail. 2016, 4, 607–616. [Google Scholar] [CrossRef] [PubMed]
- Ferrari, M.; Mottola, L.; Quaresima, V. Principles, techniques, and limitations of near-infrared spectroscopy. Can. J. Appl. Physiol. 2004, 29, 463–487. [Google Scholar] [CrossRef] [PubMed]
- Hamaoka, T.; McCully, K.K.; Quaresima, V.; Yamamoto, K.; Chance, B. Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans. J. Biomed. Opt. 2007, 12, 062105. [Google Scholar] [CrossRef] [PubMed]
- Agostoni, P.; Dumitrescu, D. How to perform and report a cardiopulmonary exercise test in patients with chronic heart failure. Int. J. Cardiol. 2019, 288, 107–113. [Google Scholar] [CrossRef] [PubMed]
- Salvioni, E.; Bonomi, A.; Magrì, D.; Merlo, M.; Pezzuto, B.; Chiesa, M.; Mapelli, M.; Baracchini, N.; Sinagra, G.; Piepoli, M.; et al. The cardiopulmonary exercise test in the prognostic evaluation of patients with heart failure and cardiomyopathies: The long history of making a one-size-fits-all suit. Eur. J. Prev. Cardiol. 2023, 30, ii28–ii33. [Google Scholar] [CrossRef] [PubMed]
- Lancellotti, P.; Pellikka, P.A.; Budts, W.; Chaudhry, F.A.; Donal, E.; Dulgheru, R.; Edvardsen, T.; Garbi, M.; Ha, J.W.; Kane, G.C.; et al. The clinical use of stress echocardiography in non-ischaemic heart disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur. Heart J. Cardiovasc. Imaging 2016, 17, 1191–1229, Erratum in Eur. Heart J. Cardiovasc. Imaging 2017, 18, 832. https://doi.org/10.1093/ehjci/jex040. [Google Scholar] [CrossRef] [PubMed]
- Lang, R.M.; Badano, L.P.; Mor-Avi, V.; Afilalo, J.; Armstrong, A.; Ernande, L.; Flachskampf, F.A.; Foster, E.; Goldstein, S.A.; Kuznetsova, T.; et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging 2015, 16, 233–270, Erratum in Eur. Heart J. Cardiovasc. Imaging 2016, 17, 412. https://doi.org/10.1093/ehjci/jew041. Erratum in Eur. Heart J. Cardiovasc. Imaging 2016, 17, 969. https://doi.org/10.1093/ehjci/jew124. [Google Scholar] [CrossRef] [PubMed]
- Adami, A.; Rossiter, H.B. Principles, insights, and potential pitfalls of the noninvasive determination of muscle oxidative capacity by near-infrared spectroscopy. J. Appl. Physiol. 2018, 124, 245–248. [Google Scholar] [CrossRef] [PubMed]
- Tandirerung, F.J.; Jamieson, A.; Hendrick, E.; Hughes, A.D.; Jones, S. Near-infrared spectroscopy (NIRS) in vivo assessment of skeletal muscle oxidative capacity: A comparison of results from short versus long exercise protocols and reproducibility in non-athletic adults. Front. Physiol. 2024, 15, 1429673. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Dorobantu, D.M.; Wadey, C.A.; Berryman, B.; Amir, N.H.; Forsythe, L.; Stuart, A.G.; Pieles, G.E.; Williams, C.A. A new protocol for a single-stage combined cardiopulmonary and echocardiography exercise test: A pilot study. Eur. Heart J. Imaging Methods Pract. 2024, 2, qyae021. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Smarz, K.; Jaxa-Chamiec, T.; Zaborska, B.; Tysarowski, M.; Budaj, A. Mechanisms of Exercise Capacity Improvement after Cardiac Rehabilitation Following Myocardial Infarction Assessed with Combined Stress Echocardiography and Cardiopulmonary Exercise Testing. J. Clin. Med. 2021, 10, 4083. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Del Punta, L.; De Biase, N.; Armenia, S.; Di Fiore, V.; Maremmani, D.; Gargani, L.; Mazzola, M.; De Carlo, M.; Mengozzi, A.; Lomonaco, T.; et al. Combining cardiopulmonary exercise testing with echocardiography: A multiparametric approach to the cardiovascular and cardiopulmonary systems. Eur. Heart J. Imaging Methods Pract. 2023, 1, qyad021. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Karsten, M.; Salvioni, E.; Palermo, P.; Mattavelli, I.; Scatigna, M.; Mapelli, M.; Grilli, G.; Pezzuto, B.; Apostolo, A.; Ribeiro, G.D.S.; et al. Periodic breathing during exercise in heart failure: Beyond the classic risk factors. Eur. Heart J. Suppl. 2025, 27, i103–i108. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Balady, G.J.; Arena, R.; Sietsema, K.; Myers, J.; Coke, L.; Fletcher, G.F.; Forman, D.; Franklin, B.; Guazzi, M.; Gulati, M.; et al. Clinician’s Guide to cardiopulmonary exercise testing in adults: A scientific statement from the American Heart Association. Circulation 2010, 122, 191–225. [Google Scholar] [CrossRef] [PubMed]
- Pálinkás, E.D.; Re, F.; Peteiro, J.; Tesic, M.; Pálinkás, A.; Torres, M.A.R.; Dikic, A.D.; Beleslin, B.; Van De Heyning, C.M.; D’Alfonso, M.G.; et al. Pulmonary congestion during Exercise stress Echocardiography in Hypertrophic Cardiomyopathy. Int. J. Cardiovasc. Imaging 2022, 38, 2593–2604. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Hanada, A.; Okita, K.; Yonezawa, K.; Ohtsubo, M.; Kohya, T.; Murakami, T.; Nishijima, H.; Tamura, M.; Kitabatake, A. Dissociation between muscle metabolism and oxygen kinetics during recovery from exercise in patients with chronic heart failure. Heart 2000, 83, 161–166. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Reddy, Y.N.V.; Carter, R.E.; Obokata, M.; Redfield, M.M.; Borlaug, B.A. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction. Circulation 2018, 138, 861–870. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Biondi, F.; Fiore, V.D.; Pancani, R.; Carrozzi, L.; De Caterina, R.; Madonna, R. Exercise testing in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease without pulmonary hypertension: A comprehensive systematic review and meta-analysis. Eur. J. Intern. Med. 2026. Epub ahead of printing. [Google Scholar] [CrossRef] [PubMed]
- Gargani, L.; Pugliese, N.R.; De Biase, N.; Mazzola, M.; Agoston, G.; Arcopinto, M.; Argiento, P.; Armstrong, W.F.; Bandera, F.; Cademartiri, F.; et al. Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation. J. Am. Coll. Cardiol. 2023, 82, 1973–1985. [Google Scholar] [CrossRef] [PubMed]
- Koirala, B.; Concas, A.; Cincotti, A.; Sun, Y.; Hernández, A.; Goodwin, M.L.; Gladden, L.B.; Lai, N. Estimation of differential pathlength factor from NIRS measurement in skeletal muscle. Respir. Physiol. Neurobiol. 2024, 326, 104283. [Google Scholar] [CrossRef] [PubMed]
- Pilotto, A.M.; Adami, A.; Mazzolari, R.; Brocca, L.; Crea, E.; Zuccarelli, L.; Pellegrino, M.A.; Bottinelli, R.; Grassi, B.; Rossiter, H.B.; et al. Near-infrared spectroscopy estimation of combined skeletal muscle oxidative capacity and O2 diffusion capacity in humans. J. Physiol. 2022, 600, 4153–4168. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Link, M.S.; Estes, N.A.M., 3rd; Maron, B.J. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement from the American Heart Association and American College of Cardiology. J. Am. Coll. Cardiol. 2015, 66, 2439–2443. [Google Scholar] [CrossRef] [PubMed]
- Piepoli, M.F.; Guazzi, M.; Boriani, G.; Cicoira, M.; Corrà, U.; Dalla Libera, L.; Emdin, M.; Mele, D.; Passino, C.; Vescovo, G.; et al. Exercise intolerance in chronic heart failure: Mechanisms and therapies. Part I Eur. J. Cardiovasc. Prev. Rehabil. 2010, 17, 637–642. [Google Scholar] [CrossRef] [PubMed]
- Mapelli, M.; Salvioni, E.; Mattavelli, I.; Vignati, C.; Galotta, A.; Magrì, D.; Apostolo, A.; Sciomer, S.; Campodonico, J.; Agostoni, P. Cardiopulmonary exercise testing and heart failure: A tale born from oxygen uptake. Eur. Heart J. Suppl. 2023, 25, C319–C325. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Wagner, P.D. The physiological basis of pulmonary gas exchange: Implications for clinical interpretation of arterial blood gases. Eur. Respir. J. 2015, 45, 227–243. [Google Scholar] [CrossRef] [PubMed]
- Willixhofer, R.; Mapelli, M.; Baracchini, N.; Campana, N.; Capovilla, T.M.; Nava, A.; Salvioni, E.; Vignati, C.; Rubbo, F.M.; Magrì, D.; et al. Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: The role of reduced O2 pulse and chronotropic incompetence in myocardial adaptation. Eur. J. Prev. Cardiol. 2025. Epub ahead of printing. [Google Scholar] [CrossRef] [PubMed]
- Willixhofer, R.; Contini, M.; Emdin, M.; Magrì, D.; Bonomi, A.; Salvioni, E.; Celeste, F.; Del Torto, A.; Passino, C.; Capelle, C.D.J.; et al. Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing-A multicentre study. ESC Heart Fail. 2025, 12, 1326–1335. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Su, Y.; Li, C.; Peng, Q.; Yin, L. Exercise Stress Echocardiography Predicts Adverse Cardiovascular Events in Hypertrophic Cardiomyopathy: A 5-Year Prospective Study. Rev. Cardiovasc. Med. 2025, 26, 41532. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Mistrulli, R.; Re, F.; Giacalone, G.; di Francesco, M.; Ferri, G.; Beato, S.; Onorato, F.; Lanzillo, C.; Canali, E.; Piepoli, M.; et al. Cardiopulmonary exercise test and stress echocardiography in Fabry cardiomyopathy: Insights into functional impairment and risk stratification. Eur. Heart J. Qual. Care Clin. Outcomes 2025, 12, 419–421. [Google Scholar] [CrossRef] [PubMed]
- Mistrulli, R.; Re, F.; Giacalone, G.; Storozhenko, T.; Ciacci, P.; Di Cristo, A.; Ferrera, A.; Gabrielli, D.; Halasz, G. Severe LVOT obstruction in HCM: Effects on exercise capacity and outcomes from cardiopulmonary exercise testing combined with stress echocardiography. Eur. Heart J. Qual. Care Clin. Outcomes 2026, qcag056. [Google Scholar] [CrossRef] [PubMed]

| Technique/Parameter | Typical Finding in Heart Failure | Clinical Significance |
|---|---|---|
| CPET: Peak VO2 | Reduced | Reflects impaired global aerobic capacity and remains a major prognostic marker in HF. |
| CPET: VE/VCO2 slope | Increased | Indicates ventilatory inefficiency and is associated with greater disease severity and worse outcomes. |
| CPET: Oxygen pulse | Reduced and/or flattened during exercise | Suggests impaired stroke volume augmentation and/or reduced peripheral oxygen extraction. |
| CPET: Exercise oscillatory ventilation | May be present | Marker of advanced cardiocirculatory dysfunction and unfavorable prognosis. |
| CPET: Chronotropic and blood pressure reserve | Abnormal | Suggests reduced cardiovascular reserve and more severe hemodynamic limitation. |
| Stress echocardiography: Contractile reserve | Reduced | Supports impaired systolic reserve, more commonly observed in HFrEF. |
| Stress echocardiography: Filling pressures (E/e′) | Increased during exercise | Suggests impaired diastolic reserve and elevated LV filling pressures, particularly relevant in HFpEF. |
| Stress echocardiography: Pulmonary pressures (sPAP/PASP) | Increased during exercise | Indicates abnormal pulmonary hemodynamic response and/or elevated left-sided filling pressures contributing to exertional dyspnea. |
| Stress echocardiography: Functional valvular regurgitation | May worsen with exercise | Reflects dynamic loading abnormalities and may contribute to reduced exercise tolerance. |
| NIRS: Resting TSI | Normal or mildly reduced | Resting values may be less informative than exercise and recovery kinetics. |
| NIRS: TSI decline during exercise | Faster and/or more pronounced | Suggests impaired matching between local oxygen delivery and utilization. |
| NIRS: Post-exercise recovery | Delayed | Consistent with impaired restoration of muscle oxygen homeostasis and altered oxidative function. |
| NIRS: tHb response | Blunted increase or minimal variation | Suggests limited local blood-volume recruitment and reduced muscle perfusion during exercise. |
| NIRS: HHb kinetics/DiffHb breakpoint | Abnormal pattern | Reflects altered peripheral O2 extraction; breakpoint may parallel late metabolic transition, although standardization remains limited. |
| Technique | Parameter | Typical Finding in PH | Clinical Significance |
|---|---|---|---|
| CPET | Peak VO2 | Reduced | Reflects impaired aerobic capacity and reduced ability to augment cardiac output during exercise because of increased pulmonary vascular load and limited RV–pulmonary arterial coupling. |
| CPET | VE/VCO2 slope | Increased | Indicates ventilatory inefficiency related to increased dead space, ventilation–perfusion mismatch, and enhanced ventilatory drive. |
| CPET | PetCO2 at rest and/or during exercise | Reduced | Suggests impaired pulmonary perfusion and inefficient CO2 delivery to the alveoli, typically reflecting ventilation–perfusion abnormalities and increased dead space. |
| CPET | O2 pulse (VO2/HR) | Reduced | Indirectly reflects impaired stroke volume augmentation and reduced forward flow during exercise. |
| CPET | VE/VO2 | Increased | Consistent with an excessive ventilatory requirement for a given oxygen uptake and inefficient ventilatory adaptation during effort. |
| CPET | Anaerobic threshold | Early, reduced, or not clearly identifiable | Reflects reduced cardiopulmonary reserve and premature transition to anaerobic metabolism. |
| CPET | Exercise SpO2 | May decrease during exertion | Supports worsening gas exchange and ventilation–perfusion mismatch during exercise. |
| Stress echocardiography | Systolic pulmonary artery pressure (sPAP/PASP) | Increased at rest and/or exaggerated rise during exercise | Reflects abnormal pulmonary vascular load and impaired adaptation of the pulmonary circulation to effort. |
| Stress echocardiography | Tricuspid regurgitation velocity (TRV) | Increased | Main Doppler surrogate for pulmonary pressure estimation and marker of elevated RV systolic pressure within the overall echocardiographic context. |
| Stress echocardiography | Right ventricular contractile reserve | Reduced | Suggests impaired ability of the right ventricle to augment systolic function during exercise. |
| Stress echocardiography | RVOT velocity–time integral (RVOT VTI) | Reduced or blunted increase during exercise | Indicates limited forward flow augmentation across the RV outflow tract and may reflect impaired stroke volume reserve. |
| Stress echocardiography | TRV/RVOT VTI ratio | Increased | May suggest increased pulmonary vascular resistance and an unfavorable relation between pressure generation and forward flow. |
| Stress echocardiography | TAPSE or RV longitudinal function | Reduced augmentation during exercise | Reflects impaired longitudinal RV reserve and reduced systolic adaptation to increased afterload. |
| Stress echocardiography | RV–pulmonary arterial coupling | Impaired | Identifies inefficient hemodynamic adaptation to exercise and may have prognostic relevance. |
| Modality | Key Parameter | Typical Finding in PAD | Pathophysiological/Clinical Significance |
|---|---|---|---|
| CPET | Peak VO2 | Reduced | Reflects impaired global exercise capacity, resulting from the combined effects of limb ischemia, deconditioning, endothelial dysfunction, and frequent cardiovascular comorbidities. |
| CPET | Anaerobic threshold (AT) | Early onset/reduced | Suggests reduced functional reserve and earlier transition to anaerobic metabolism during exercise. |
| CPET | Oxygen pulse | Reduced | May indicate limited stroke volume augmentation and/or reduced peripheral oxygen utilization during exercise; interpretation should consider concomitant cardiac disease. |
| CPET | VE/VCO2 slope | Normal or mildly increased; may be higher in selected patients | Usually less specific for PAD itself, but may suggest inefficient ventilatory adaptation or associated cardiopulmonary comorbidity. |
| NIRS | ΔTSI during exercise | More rapid and pronounced decline | Marker of exercise-induced muscle ischemia and impaired local oxygen delivery to the active limb musculature. |
| NIRS | TSI recovery time | Prolonged | Reflects delayed reoxygenation after exercise and is consistent with impaired vascular reserve and microvascular function. |
| NIRS | HHb response | Increased | Suggests enhanced local oxygen extraction in the setting of reduced convective oxygen delivery. |
| Stress echocardiography | Ventricular reserve/wall motion | Usually preserved unless concomitant cardiac disease is present | Useful to exclude inducible myocardial ischemia or central cardiac limitation as contributors to exercise intolerance in PAD. |
| Modality | Key Parameter | Typical Finding in Trained Athletes/Abnormal Pattern of Interest | Pathophysiological/Clinical Significance |
|---|---|---|---|
| CPET | Peak VO2 | Usually markedly elevated in trained athletes; values > 50 mL/kg/min or >120% of predicted may support physiological athletic remodeling rather than hypertrophic cardiomyopathy in athletes with equivocal left ventricular hypertrophy | Reflects high global aerobic capacity and may aid in differentiating athlete’s heart from cardiomyopathic phenotypes when interpreted within a multimodality framework. |
| CPET | Ventilatory thresholds (VT1/VT2) | Delayed occurrence at higher workloads | Indicates superior aerobic efficiency and training adaptation; abnormal early thresholds may suggest deconditioning or occult disease. |
| CPET | VE/VCO2 slope | Typically normal or low–normal in healthy athletes | Preserved ventilatory efficiency; abnormal elevation should raise suspicion for cardiopulmonary limitation or inefficient exercise response. |
| CPET | Oxygen pulse | Increased with progressive exercise | Surrogate of effective stroke volume augmentation and peripheral oxygen extraction during exertion; a flattened pattern may suggest cardiovascular limitation. |
| NIRS | TSI decline during exercise | Progressive fall during increasing workload | Reflects physiological augmentation of skeletal muscle oxygen extraction; the pattern may help characterize local metabolic stress and muscular efficiency. |
| NIRS | Recovery kinetics/reoxygenation time | Rapid post-exercise recovery in well-conditioned athletes | Provides information on peripheral vascular responsiveness and muscle oxidative capacity; delayed recovery may suggest impaired peripheral conditioning or incomplete recovery status. |
| NIRS | HHb/DiffHb breakpoint | Detectable near metabolic transition zones | May complement CPET threshold analysis by identifying peripheral metabolic transition points during incremental exercise. |
| Stress echocardiography | LV systolic and diastolic reserve | Preserved or enhanced augmentation during exercise | Supports physiological adaptation to training; impaired reserve may suggest underlying myocardial disease. |
| Stress echocardiography | Regional wall motion | Normal in physiological adaptation | Useful for detecting exercise-induced ischemia or occult structural heart disease in symptomatic or high-risk athletes. |
| Stress echocardiography | Dynamic LVOT gradient/valvular behavior | Usually absent or physiologically mild | Helps distinguish athlete’s heart from hypertrophic cardiomyopathy or other structural causes of exertional symptoms. |
| Integrated interpretation | CPET + ESE + NIRS profile | Concordant high performance with preserved central reserve and efficient peripheral oxygen handling | Supports physiological athletic adaptation; discrepant central or peripheral findings may orient toward occult pathology, maladaptation, or suboptimal training response. |
| Modality | Key Parameter | Typical Finding in Cardiomyopathies | Pathophysiological/Clinical Significance |
|---|---|---|---|
| CPET | Peak VO2 | Reduced | Reflects impaired global exercise capacity and is a major marker of functional limitation and prognosis across cardiomyopathy phenotypes. |
| CPET | Percent-predicted peak VO2 | Reduced | Particularly useful for risk stratification, especially in dilated cardiomyopathy, where it may support timing of advanced heart failure therapies. |
| CPET | VE/VCO2 slope | Increased | Indicates ventilatory inefficiency and is associated with worse functional status and adverse outcomes. |
| CPET | Chronotropic response | Abnormal or blunted | Suggests impaired cardiovascular adaptation to exercise and may contribute to exercise intolerance. |
| CPET | Ventilatory thresholds | Early or reduced | Reflect reduced cardiopulmonary reserve and premature metabolic transition during effort. |
| NIRS | TSI decline during exercise | Faster and/or more pronounced | Suggests impaired balance between peripheral oxygen delivery and utilization, possibly related to microvascular dysfunction or altered oxidative metabolism. |
| NIRS | Recovery kinetics | Delayed | Indicates impaired restoration of muscle oxygen homeostasis and may reflect reduced oxidative capacity. |
| NIRS | HHb/DiffHb breakpoint | Detectable or abnormal | May complement ventilatory threshold assessment and provide insight into peripheral metabolic transition. |
| NIRS | Peripheral oxygenation profile | Abnormal despite modest central limitation in some patients | Supports the contribution of skeletal muscle and microcirculatory dysfunction to exercise intolerance. |
| Stress echocardiography | Contractile reserve | Reduced in advanced disease; preserved reserve associated with better outcome | Helps stratify systolic functional reserve and prognosis, particularly in dilated cardiomyopathy. |
| Stress echocardiography | Diastolic reserve/filling pressures | Abnormal increase during exercise | Indicates impaired diastolic adaptation and contributes to exertional dyspnea and reduced exercise tolerance. |
| Stress echocardiography | LVOT obstruction | Dynamic increase during exercise in selected patients | Particularly relevant in hypertrophic cardiomyopathy, where exercise-induced obstruction may be a major determinant of symptoms. |
| Stress echocardiography | Pulmonary pressure response | Increased during exercise | Suggests abnormal hemodynamic adaptation and may identify patients with more advanced functional limitation. |
| Stress echocardiography | Exercise B-lines/pulmonary congestion | May appear or increase with stress | Supports elevated filling pressures and exercise-induced pulmonary congestion. |
| Integrated interpretation | CPET + ESE + NIRS profile | Concordant central and/or peripheral abnormalities | Improves phenotypic characterization, refines risk stratification, and supports individualized therapeutic and exercise prescription strategies. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Halasz, G.; Mistrulli, R.; Di Francesco, M.; Giacalone, G.; Ferri, G.; Beato, S.; Moschella Orsini, F.; Nardecchia, G.; Corica, B.; Colivicchi, F.; et al. Integrating Cardiopulmonary Exercise Testing, Stress Echocardiography and Near-Infrared Spectroscopy for Multimodal Assessment of Exercise Intolerance: A Narrative Review. Healthcare 2026, 14, 1511. https://doi.org/10.3390/healthcare14111511
Halasz G, Mistrulli R, Di Francesco M, Giacalone G, Ferri G, Beato S, Moschella Orsini F, Nardecchia G, Corica B, Colivicchi F, et al. Integrating Cardiopulmonary Exercise Testing, Stress Echocardiography and Near-Infrared Spectroscopy for Multimodal Assessment of Exercise Intolerance: A Narrative Review. Healthcare. 2026; 14(11):1511. https://doi.org/10.3390/healthcare14111511
Chicago/Turabian StyleHalasz, Geza, Raffaella Mistrulli, Marco Di Francesco, Guido Giacalone, Gianluca Ferri, Stefano Beato, Francesca Moschella Orsini, Giovanni Nardecchia, Bernadette Corica, Furio Colivicchi, and et al. 2026. "Integrating Cardiopulmonary Exercise Testing, Stress Echocardiography and Near-Infrared Spectroscopy for Multimodal Assessment of Exercise Intolerance: A Narrative Review" Healthcare 14, no. 11: 1511. https://doi.org/10.3390/healthcare14111511
APA StyleHalasz, G., Mistrulli, R., Di Francesco, M., Giacalone, G., Ferri, G., Beato, S., Moschella Orsini, F., Nardecchia, G., Corica, B., Colivicchi, F., Di Fusco, S. A., Re, F., & Gabrielli, D. (2026). Integrating Cardiopulmonary Exercise Testing, Stress Echocardiography and Near-Infrared Spectroscopy for Multimodal Assessment of Exercise Intolerance: A Narrative Review. Healthcare, 14(11), 1511. https://doi.org/10.3390/healthcare14111511

